ArticleJournal for immunotherapy of cancer2021
Correction: Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.